Dataset Information

Development of a Microsphere-Based System to Facilitate Real-Time Insulin Monitoring.

ABSTRACT: The speed of insulin absorption after subcutaneous delivery is highly variable. Incorrect assumptions about insulin pharmacokinetics compromise effective glycemic regulation. Our ultimate goal is to develop a system to monitor insulin levels in vivo continuously, allowing pharmacokinetic parameters to be calculated in real time. We hypothesize that a bead-based detection system can be run on a flow-through microfluidic platform to measure insulin in subcutaneous fluid sampled via microdialysis. As a first step in development, we focused on microsphere-based measurement of insulin.Polystyrene microspheres coated with an anti-insulin monoclonal antibody were exposed to insulin-containing solutions, and after addition of a fluorescently labeled anti-insulin monoclonal antibody with a distinct epitope, bead-associated fluorescence was detected by fluorescence microscopy in 96-well plates or in a flow-through, microfluidic platform.The bead detection system in plates had a linear range in buffer for regular human insulin (RHI), insulin lispro, and insulin aspart of 15-1115 µIU/ml, 14-976 µIU/ml, and 25-836 µIU/ml, respectively. Measurement on plasma samples demonstrated proportionality between basal and peak insulin levels similar to the laboratory reference method. Preliminary results in a polydimethylsiloxane-based, flow-through, microfluidic platform showed a strong signal at peak insulin levels.We have developed a microsphere-based system to rapidly measure levels of insulin and insulin analogs. We have further demonstrated proof of concept that this bead detection system can be implemented in a lab-on-a-chip format, which will be further developed and combined with microdialysis for real-time monitoring of insulin in vivo.

SUBMITTER: Kahanovitz L

PROVIDER: S-EPMC5038538 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Development of a Microsphere-Based System to Facilitate Real-Time Insulin Monitoring.

Kahanovitz Lindy L Seker Erkin E Marks Robert S RS Yarmush Martin L ML Konry Tania T Russell Steven J SJ

Journal of diabetes science and technology 20160503 3

<h4>Background</h4>The speed of insulin absorption after subcutaneous delivery is highly variable. Incorrect assumptions about insulin pharmacokinetics compromise effective glycemic regulation. Our ultimate goal is to develop a system to monitor insulin levels in vivo continuously, allowing pharmacokinetic parameters to be calculated in real time. We hypothesize that a bead-based detection system can be run on a flow-through microfluidic platform to measure insulin in subcutaneous fluid sampled ...[more]

PMID: 26721524

Similar Datasets

Project description:Health care is one of the least funded sectors in Bangladesh and many other similar developing countries. People living in rural and remote areas do not have access to proper health care, and when they do, it is too expensive. This research aimed to develop a real-time health monitoring system that is cheap, easy to use, and accessible by doctors and patients. The system consists of several Internet of Things (IoT)-based sensors connected to an Arduino microprocessor, which thus measures the vital body signs of the patients. The measured readings are then transmitted to an Android application on a smartphone via a Bluetooth module. The sensors are connected to analog inputs. These sensors measure analog data, which is amplified by the microprocessor after being sorted. Doctors can also carry out the diagnosis of ailments using the data collected remotely from the patient. An Android-based mobile application that interfaces with a web-based application is implemented for efficient patients-doctors dual real-time communication. The Android application, which is connected to a MySQL database, updates the said database, which updates and displays the readings on a website accessible by both doctors and patients. Initially, the health monitor was tested using an Arduino Integrated Development Environment (IDE) monitor and a single user. Once initial simulations were successful, the proposed system was tested on five different real-human test subjects. The testing of the wireless health monitor produced successful results that measured patient vitals with a high level of accuracy. The proposed IoT-based system monitors vital signs such as the patient's body temperature, heart rate, ECG, SpO2 levels, blood pressure, and glucose levels. This system also includes a medical treatment plan by the doctors. The proposed system is novel as it integrates the IoT-based patient monitoring system with telemedicine. This proposed system has different sensors for real-time measuring the vital signs of the human body. A mobile and web application have also been integrated with this system for real-time remote patient monitoring and treatment plan. There are now systems available that only offer a telemedicine facility, where patients and doctors can have discussions, but do not have an IoT-based patient vital sign monitoring system integrated with telemedicine. The proposed system in this paper has the facility of IoT-based patient vital signs monitoring integrated with telemedicine, which makes this research work novel. The proposed system will increase the life expectancy of people throughout the world.

Dataset Information

Development of a Microsphere-Based System to Facilitate Real-Time Insulin Monitoring.

Publications

Development of a Microsphere-Based System to Facilitate Real-Time Insulin Monitoring.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets